|
Press Releases - 2007
| Dec. 2, 2007 |
- |
TK Signal, a Hadasit Bio-Holdings Portfolio Company, Signs a Licensing Agreement for New Oncology Therapy.
|
|
| Nov. 29, 2007 |
- |
Is Israeli Biomed Undervalued?
|
|
| Nov. 18, 2007 |
- |
InCure, a Hadasit Bio-Holdings Portfolio Company, Announces Positive Results of a Trial to Detect Cancerous Metastases in Human Blood
|
|
| Sep. 10, 2007 |
- |
Hadasit Bio Holdings - Profiled in "The Marker"
Portfolio and Strategic Details (Hebrew)
|
|
| Sep. 2, 2007 |
- |
Teva will invest $1 million in Cell Cure, the Hadasit Bio-Holdings portfolio company that is developing an innovative treatment for Parkinson’s
Cell Cure specializes in embryonic stem cell research, a field in which the Hadassah Medical Center is considered a world leader
|
|
| Sep. 2, 2007 |
- |
"Globes" : Teva to invest in stem cell start-up Cell Cure
The Hadasit Bio portfolio company previously received funding from the Michael J. Fox Foundation.
|
|
| Aug. 30, 2007 |
- |
Thrombotech, an HBL subsidiary, announces that Clal Biotechnology Industries will exercise its investment option; other shareholders will also invest in the company
Exercise of the option will immediately inject $500,000 into the company; shareholders will invest another $1.25 million to pave the way for clinical trials.
|
|
| Jul. 31, 2007 |
- |
Antitope Ltd., (UK) and ProtAb Ltd. (Israel) – an HBL Portfolio Company, Announce Antibody Research Agreement
|
|
| Jul. 11, 2007 |
- |
PFIZER VP: "We Found Israel to be the Ideal Place to Conduct Clinical Trials of the Highest Standard."
Pfizer delegation visited Israel to explore business opportunities in Israel
|
|
| Jun. 8, 2007 |
- |
Hadasit + HBL to Appear in Medical Device Daily
View Attached PDF File - See Pages 1 & 8
|
|
| Jun. 5, 2007 |
- |
Tolarex Ltd., a Portfolio Company of Hadasit Bio-Holdings, has Named Alon Moran as its CEO
|
|
| May. 27, 2007 |
- |
Hadasit Bio-Holdings Ltd. Announced that Consensus Business Group, one of England’s Leading Private Investment Groups, has acquired Hadasit stock for $ 2 M, by way of a Private Placement
|
|
| May. 9, 2007 |
- |
Embryonic stem cells trial on track to start
|
|
| Apr. 15, 2007 |
- |
Michael J. Fox Foundation puts faith in Israeli Parkinson's research
Publihsed in Israel 21C - A Focus Beyond
|
|
| Mar. 30, 2007 |
- |
Hadasit Bio-Holdings has Named Ophir Shahaf as its CEO and Rafi Hofstein as Chairman of the Board
|
|
| Feb. 18, 2007 |
- |
"Biomed In Israel is about to Leap Forward"
|
|
| Jan. 30, 2007 |
- |
"Red Herring" : Stem Cell Firm Licenses Patents
Singapore’s ES Cell International signs deal with Scotland’s ITI Life Sciences.
|
|
| Jan. 24, 2007 |
- |
Cell Cure Neurosciences, Awarded Significant Funding from the Michael J. Fox Foundation for Parkinson's Research
Cell Cure Neurosciences is a Hadasit Bio Holdings Portfolio Company
|
|
| Jan. 9, 2007 |
- |
Verto, a Subsidiary of Hadasit Bio-Holdings (HBL), Announced Commencement of Human Clinical Trials for LupusorbTM for the Innovative Treatment of Lupus (Phase I/II)
To be published Shortly
|
|
| Jan. 7, 2007 |
- |
Cell Cure Neurosciences, a Hadasit Bio-Holdings Portfolio Company, Awarded Grant from the Israeli A.L.S Association
|
|
 |
|
 |
| |
Press Releases Archive
|
|
 |
|
 |
|
